AFib risk with cancer drugs underestimatedApril 12, 2023Hodgkin LymphomaAMLMultiple MyelomaNon-Hodgkin Lymphoma
Atorvastatin cut anthracycline cardiac dysfunction in lymphomaMarch 4, 2023Hodgkin LymphomaNon-Hodgkin Lymphoma
ASH 2022: New clinical data challenge long-held assumptionsDecember 7, 2022Mixed TopicsTransplantHodgkin LymphomaALLPatient & Survivor CareMantle Cell LymphomaAML
Drug shortages plague hematology, but preparedness helpsJuly 18, 2022CLLALLHodgkin LymphomaMixed TopicsBusiness of MedicineB Cell LymphomaMantle Cell Lymphoma
Third-generation Black woman physician makes cancer research historyMay 24, 2022Mixed TopicsALLB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaDiversity in MedicineAML
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
Survivor’s story foreshadows one of oncology’s greatest successesApril 14, 2022Hodgkin LymphomaTransplantCLL
Repurposed drug could revolutionize stem cell transplantationMarch 18, 2022TransplantB Cell LymphomaHodgkin LymphomaMultiple MyelomaPediatricsDLBCLCLL
DKMS: Small nonprofit to world’s largest stem cell donor registryJanuary 21, 2022ALLCOVID-19 UpdatesMixed TopicsMultiple MyelomaDLBCLB Cell LymphomaAML
Frontline brentuximab vedotin shows promise in high-risk pediatric Hodgkin lymphomaApril 21, 2021Hodgkin LymphomaPediatrics
